Paperless clinical trials: Myth or reality?
Sandeep K Gupta
Department of Pharmacology, Dhanalakshmi Srinivasan Medical College and Hospital, Siruvachur, Perambalur, Tamil Nadu, India
There is an urgent need to expedite the time-to-market for new drugs and to make the approval process simpler. But clinical trials are a complex process and the increased complexity leads to decreased efficiency. Hence, pharmaceutical organizations want to move toward a more technology-driven clinical trial process for recording, analyzing, reporting, archiving, etc., In recent times, the progress has certainly been made in developing paperless systems that improve data capture and management. The adaptation of paperless processes may require major changes to existing procedures. But this is in the best interests of these organizations to remain competitive because a paperless clinical trial would lead to a consistent and streamlined framework. Moreover, all major regulatory authorities also advocate adoption of paperless trial. But challenges still remain toward implementation of paperless clinical trial process.
Dr. Sandeep K Gupta
Department of Pharmacology, Dhanalakshmi Srinivasan Medical College and Hospital, Siruvachur, Perambalur, Tamil Nadu
|How to cite this article:|
Gupta SK. Paperless clinical trials: Myth or reality?.Indian J Pharmacol 2015;47:349-353
|How to cite this URL:|
Gupta SK. Paperless clinical trials: Myth or reality?. Indian J Pharmacol [serial online] 2015 [cited 2020 Aug 5 ];47:349-353
Available from: http://www.ijp-online.com/article.asp?issn=0253-7613;year=2015;volume=47;issue=4;spage=349;epage=353;aulast=Gupta;type=0